Tempus AI, Inc. (TEM )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol TEM
- Company Tempus AI, Inc.
- Price $47.22
- Changes Percentage -2.11
- Change -1.02
- Day Low $45.46
- Day High $49.13
- Year High $91.45
- Year Low $22.89
- Market Cap $7,893,715,930
- Price Avg 50 EMA (D) $57.56
- Price Avg 200 EMA (D) $49
- Exchange NASDAQ
- Volume 7,692,606
- Average Volume 13,489,610
- Open $48.27
- Previous Close $48.24
- EPS -6.29
- PE -7.51
- Earnings Announcement 2025-05-28 12:00:00
- Shares Outstanding $167,168,910
Company brief: TEMPUS AI, INC. (TEM )
- Healthcare
- Healthcare
- Mr. Eric P. Lefkofsky
- https://www.tempus.com
- US
- N/A
- 03-28-2012
Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc in January 2023. Tempus AI, Inc was incorporated in 2015 and is headquartered in Chicago, Illinois.
TEM Corporation News
Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock?
zacks.com -- The February 2025 acquisition of Ambry Genetics further expands TEM's genomics capabilities with a West Coast lab and enhanced inherited risk testing....
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting
businesswire.com -- CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is scheduled to exh...